Results 191 to 200 of about 14,534 (309)

Comparison of In‐Office and General Anesthesia Biopsies for Oropharyngeal Squamous Cell Carcinoma in a Public Healthcare System

Head &Neck, EarlyView.
ABSTRACT Background We compared treatment delays, costs, and management impact between oropharyngeal squamous cell carcinoma (OPSCC) patients undergoing in‐office versus general anesthesia panendoscopy‐guided biopsies in two large tertiary centers in a public healthcare system. Methods All OPSCC patients included were treated between 2010 and 2024 with
Samuel Bellavance, Michel Khoury, Justine Colivas, Jonathan Primiani, Gabriel Dayan, Eric Bissada, Tareck Ayad, Apostolos Christopoulos, Jean‐Claude Tabet, Louis Guertin, Paul Tabet   +10 more
wiley   +1 more source

An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics. [PDF]

Int J Toxicol
Sisler JD, Andersson P, Brown A, Harbison C, Irrechukwu O, Lightfoot H, Maes M, Mukherjee S, Parry JD, Schumacher J, Westlind Johnsson A, Yang Y, Harper TA.   +12 more
europepmc   +1 more source

Re: Arsenic carcinogenicity testing. [PDF]

Environmental Health Perspectives, 1998
openaire   +1 more source

Poor Diet and Oral Cavity Cancer Risk in Smoking and Non‐Smoking Men and Women: An Analysis of Three US Cohorts

Head &Neck, EarlyView.
ABSTRACT Introduction Oral cavity cancer (OCC) incidence is rising among non‐smokers and younger individuals without traditional risk factors. While carcinogenic exposures such as tobacco and alcohol are well studied, the association between unhealthy dietary patterns and OCC has been minimally explored.
Mateo Useche, Luis Gomez‐Castillo, Kara Cushing‐Haugen, Rocco Ferrandino, Neal Futran, Emily Marchiano, Cristina P. Rodriguez, Holly R. Harris, Brittany Barber   +8 more
wiley   +1 more source

Oncotransformation in Bhas 42 Cell Transformation Assay by Typical Non-Genotoxic Carcinogens, PFOA and PFOS, and Time-Course Transcriptome Analysis. [PDF]

Biomolecules
Ohmori K.
europepmc   +1 more source

Toward Explainable Carcinogenicity Prediction: An Integrated Cheminformatics Approach and Consensus Framework for Possibly Carcinogenic Chemicals. [PDF]

J Chem Inf Model
Duy HA, Srisongkram T.
europepmc   +1 more source

Naphthalene: MAK Value Documentation, addendum - Translation of the German version from 2022. [PDF]

MAK Collect Occup Health Saf
Hartwig A, MAK Commissionhttps://www.dfg.de/en/about-us/statutory-bodies/senate/health-hazards/list.   +1 more
europepmc   +1 more source

Tetrabromobisphenol A: MAK Value Documentation - Translation of the German version from 2023. [PDF]

MAK Collect Occup Health Saf
Hartwig A, MAK Commission .
europepmc   +1 more source

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia, Anne‐Sophie van der Werf‐'t Lam, Madalina Cabuta, Maartje Nielsen, Noah C. Helderman   +4 more
wiley   +1 more source

Guidance on the scientific data requirements for an application for authorisation of a food additive submitted under Regulation (EC) No 1331/2008. [PDF]

EFSA J
EFSA Panel on Food Additives and Flavourings (FAF), Castle L, Andreassen M, Aquilina G, Bastos ML, Boon P, Fallico B, FitzGerald R, Frutos Fernandez MJ, Grasl-Kraupp B, Gundert-Remy U, Gürtler R, Houdeau E, Kurek M, Louro H, Morales P, Passamonti S, Barmaz S, Carfì M, Civitella C, Gagliardi G, Lodi F, Martino C, Mazzoli E, Mech A, Rasinger JD, Rincon AM, Ruggeri L, Smeraldi C, Tard A, Zakidou P.   +30 more
europepmc   +1 more source